Activation of the IGF1R pathway potentially mediates acquired resistance to mutant-selective 3rd-generation EGF receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer

Ji Hyun Park(Ulsan College), Jae Cheol Lee(Ulsan College)

Oncotarget

March 9, 2016

10.18632/oncotarget.8013

Cited by 70

Related Papers

Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer

|Nature Cancer|2023|46

Autophagosome-Mediated EGFR Down-Regulation Induced by the CK2 Inhibitor Enhances the Efficacy of EGFR-TKI on EGFR-Mutant Lung Cancer Cells with Resistance by T790M

|PLoS ONE|2014|28

Role of IGF-Binding Protein 3 in the Resistance of EGFR Mutant Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitors

|PLoS ONE|2013|11